Trials / Sponsors / Shanghai PerHum Therapeutics Co., Ltd.
Shanghai PerHum Therapeutics Co., Ltd.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas SAR | Phase 1 | 2021-12-30 |
| Active Not Recruiting | A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors Solid Tumor, Gastric Cancer, Breast Cancer | Phase 1 | 2020-07-09 |
| Terminated | A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors Solid Tumor, Soft Tissue Sarcoma, Gastric Cancer | Phase 1 | 2019-05-16 |
| Terminated | Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcino Renal Cell Carcinoma | Phase 1 / Phase 2 | 2018-03-26 |